US reaches deal with Moderna for omicron COVID-19 vaccine

WASHINGTON — The Biden administration mentioned Friday it has reached an settlement with Moderna to purchase 66 million doses of the company’s subsequent technology of COVID-19 vaccine that targets the extremely transmissible omicron variant, sufficient provide this winter for all who need the upgraded booster.

The order of the bivalent shot follows the announcement final month that the federal authorities had secured 105 million doses of an identical vaccine from rival drugmaker Pfizer. Both orders are scheduled for supply within the fall and winter, assuming regulators log out on their effectiveness. The Pentagon mentioned the Moderna contract was price $1.74 billion.

The omicron pressure has been dominant within the U.S. since December, with the BA.5 subvariant now inflicting a large wave of infections throughout the nation, even infecting President Joe Biden.

“We must stay vigilant in our fight against COVID-19 and continue to expand Americans’ access to the best vaccines and treatments,” Health and Human Services Secretary Xavier Becerra mentioned in a press release. “As we look to the fall and winter, we’re doing just that — ensuring Americans have the tools they need to stay safe and help keep our nation moving forward.”

The U.S. orders with Pfizer and Moderna embrace choices to buy 300 million doses every, however reaching that complete would require extra funding from Congress, the Biden administration mentioned.

About 261 million Americans have acquired at the least one COVID-19 shot, however solely 108 million have acquired a booster.


Follow AP’s protection of the coronavirus pandemic at

Back to top button